ARTICLES BY THIS AUTHOR
- 6/3/2021
NACDS urges lawmakers to cement pharmacy’s pandemic-era gains
The National Association of Chain Drug Stores emphasized pharmacy’s central position in the nation’s COVID-19 response in urging Congress not to roll back access and its preparedness achieved during the pandemic. - 6/3/2021
FDA approves Scynexis’ Brexafemme
The product — a treatment for vaginal yeast infections — is expected to be launched in the second half of this year. - 6/2/2021
NCPA to CMS: Address 91,500% hike in DIR fees
The typical community pharmacy now pays roughly $81,000 per year in DIR fees, according to research from the National Community Pharmacists Association. - 6/2/2021
Hikma launches estradiol valerate injection
Estradiol valerate injection had a market value of roughly $16 million in the 12 months ending March 2021, according to IQVIA. - 6/2/2021
Zydus Cadila receives tentative FDA OK for generic Tagrisso
Zydus Cadila's osimertinib provides a generic treatment for lung cancer. - 6/2/2021
NACDS’ Boutte joins Reagan-Udall Foundation board
Christie Boutte will serve alongside other board members from academia, consumer groups, and medical product and food industries, as well as health care and other disciplines shaping health care delivery. - 6/1/2021
NCPA lauds Tennessee governor for signing PBM bill into law
The legislation prohibits PBMs from reimbursing pharmacies below their acquisition costs, among other provisions. - 6/1/2021
Hy-Vee dietitians offer free virtual nutrition store tours in Spanish
Hy-Vee also is offering individual dietitian services in Spanish through its virtual dietitian platform. - 6/1/2021
NCPA survey: Tight labor market squeezing local pharmacies
NCPA’s recent survey of independent pharmacists found that 80% of local pharmacies can’t find workers. - 6/1/2021
Camber intros generic Banzel
Camber's rufinamide tablets are used with other medications to control seizures in people who have Lennox-Gastaut syndrome.